Is a complete GLUE research report available?

No complete published report is available for Monte Rosa Therapeutics, Inc. (GLUE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · USD

$10.9

+0.20 (+1.9%)· Recorded snapshot

Market cap	926.5M
Revenue (ttm)	28.7M
Net income (ttm)	-161.1M
EPS (ttm)	-$1.75
Shares out	85.3M
Volume	1,319,218
Beta	1.37

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 28.7M
Net income (ttm): -161.1M
EPS (ttm): -$1.75
Market cap: 926.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001826457
Company name	Monte Rosa Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	61225M102
Earnings date	2026-11-09
Earnings time	bmo
Employees	173
Employees change	31
Employees growth	21.83%
Enterprise value	$343.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2019
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2021-06-24
Is primary listing	Yes
Is SPAC	No
ISIN number	US61225M1027
Last 10-K release date	2026-03-17
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$926.5M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$10.86
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	GLUE
U.S. state	Massachusetts
Website	https://www.monterosatx.com

Metric

Value

Amount currency

USD

CIK code

0001826457

Company name

Monte Rosa Therapeutics, Inc.

Country

United States

Country code

CUSIP number

61225M102

Earnings date

2026-11-09

Earnings time

bmo

Employees

173

Employees change

Employees growth

21.83%

Enterprise value

$343.4M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2019

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2021-06-24

Is primary listing

Yes

Is SPAC

ISIN number

US61225M1027

Last 10-K release date

2026-03-17

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$926.5M

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$10.86

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

GLUE

U.S. state

Massachusetts

Website

https://www.monterosatx.com

Metric	Value
Earnings yield	-16.07%
EV/Sales	11.66x
FCF / EV yield	-9.58%
FCF yield	-3.49%
Forward EV/Sales	5.16x
Forward P/S	14.13x
P/B ratio	1.86x
P/S ratio	31.96x
Price / tangible book value	1.88x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-16.07%

EV/Sales

11.66x

FCF / EV yield

-9.58%

FCF yield

-3.49%

Forward EV/Sales

5.16x

Forward P/S

14.13x

P/B ratio

1.86x

P/S ratio

31.96x

Price / tangible book value

1.88x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Operating margin	-633.04%
Pretax margin	-570.8%
Profit per employee	$-931,306
Revenue per employee	$166,052
ROA	-21.63%
ROA (5Y)	-18.15%
ROCE	-28.8%
ROE	-42.66%
ROE (5Y)	-37.72%
ROIC	-27.24%
SBC / revenue	71.68%
Tax / revenue	-9.95%

Metric

Value

Operating margin

-633.04%

Pretax margin

-570.8%

Profit per employee

$-931,306

Revenue per employee

$166,052

ROA

-21.63%

ROA (5Y)

-18.15%

ROCE

-28.8%

ROE

-42.66%

ROE (5Y)

-37.72%

ROIC

-27.24%

SBC / revenue

71.68%

Tax / revenue

-9.95%

Metric	Value
EPS growth years	2
Net income growth years	2
Revenue growth	-83.86%
Revenue growth (Q)	-61.34%
Revenue growth (QoQ)	113.02%
Revenue growth years	1

Metric

Value

EPS growth years

Net income growth years

Revenue growth

-83.86%

Revenue growth (Q)

-61.34%

Revenue growth (QoQ)

113.02%

Revenue growth years

Metric	Value
Capital expenditures	$-8M
Depreciation and amortization	$8.1M
EBIT	$-181.9M
EBITDA	$-173.7M
EPS	$-1.75
FCF per share	$-0.38
Financing cash flow	$361.5M
Free cash flow	$-32.1M
Free cash flow minus SBC	$-52.7M
Gross profit	$-133.6M
Income taxes	$-2.9M
Investing cash flow	$-316.8M
Net cash flow	$20.7M
Net income	$-161.1M
Operating cash flow minus SBC	$-44.7M
Operating income	$-181.9M
Revenue	$28.7M
Stock-based compensation	$20.6M

Metric

Value

Capital expenditures

$-8M

Depreciation and amortization

$8.1M

EBIT

$-181.9M

EBITDA

$-173.7M

EPS

$-1.75

FCF per share

$-0.38

Financing cash flow

$361.5M

Free cash flow

$-32.1M

Free cash flow minus SBC

$-52.7M

Gross profit

$-133.6M

Income taxes

$-2.9M

Investing cash flow

$-316.8M

Net cash flow

$20.7M

Net income

$-161.1M

Operating cash flow minus SBC

$-44.7M

Operating income

$-181.9M

Revenue

$28.7M

Stock-based compensation

$20.6M

Metric	Value
Altman Z-Score	2.09
Book value per share	$5.72
Debt / equity	0.08
Long-term assets	$59.8M
Long-term liabilities	$144.2M
Net cash (debt)	$583.1M
Net cash / market cap	63.52%
Net cash growth	133.75%
Net debt / equity	-1.2
Piotroski F-Score	2
Property, plant and equipment	$54M
Shareholders' equity	$487.3M
Tangible book value	$487.3M
Tangible book value per share	$5.72
Total assets	$691.2M
Total cash	$621.1M
Total debt	$38M
Total liabilities	$203.9M
WACC	11.31%

Metric

Value

Altman Z-Score

2.09

Book value per share

$5.72

Debt / equity

0.08

Long-term assets

$59.8M

Long-term liabilities

$144.2M

Net cash (debt)

$583.1M

Net cash / market cap

63.52%

Net cash growth

133.75%

Net debt / equity

-1.2

Piotroski F-Score

Property, plant and equipment

$54M

Shareholders' equity

$487.3M

Tangible book value

$487.3M

Tangible book value per share

$5.72

Total assets

$691.2M

Total cash

$621.1M

Total debt

$38M

Total liabilities

$203.9M

WACC

11.31%

Metric	Value
Asset turnover	0.05
Current assets	$631.4M
Current liabilities	$59.7M
Current ratio	10.58
Net working capital	$-44.7M
Quick ratio	10.49
Working capital	$571.7M
Working capital turnover	0.07

Metric

Value

Asset turnover

0.05

Current assets

$631.4M

Current liabilities

$59.7M

Current ratio

10.58

Net working capital

$-44.7M

Quick ratio

10.49

Working capital

$571.7M

Working capital turnover

0.07

Metric	Value
Buyback yield / dilution	-11.91%
Dividend yield	0%
Shareholder yield	-11.91%

Metric

Value

Buyback yield / dilution

-11.91%

Dividend yield

Shareholder yield

-11.91%

Metric	Value
150-day SMA	$16.94
1D price change	1.88%
1M price change	-8.92%
1M total return	-8.92%
1W price change	-5.63%
1W total return	-5.63%
1Y price change	-12.99%
1Y return CAGR	-13%
1Y total return	-12.99%
20-day SMA	$10.49
200-day SMA	$17.51
3M price change	-52.48%
3M total return	-52.48%
3Y price change	285.61%
3Y return CAGR	56.8%
3Y total return	285.61%
50-day SMA	$12.25
50-day SMA vs 200-day SMA	50under200
52-week high	$25.77
52-week high date	2026-01-08
52-week low	$9.68
52-week low date	2026-10-07
5Y price change	-58.99%
5Y return CAGR	-16.33%
5Y total return	-58.99%
6M price change	-44.43%
6M total return	-44.43%
All-time high	$45.56
All-time high date	2021-09-07
All-time low	$2.44
All-time low date	2023-10-25
Average true range (ATR)	$0.61
Average volume	1.6M
Beta (1Y)	2.37
Beta (2Y)	1.4
Beta (5Y)	1.37
Change from 52-week high	-57.86%
Change from 52-week low	12.19%
Change from all-time high	-76.47%
Change from all-time low	339.34%
Change from open	0.74%
Day's gap	1.13%
Dollar volume	$14.3M
High price	$10.87
Low price	$10.49
Monthly RSI	46.79
Open price	$10.78
Position in 52-week range	97.37%
Premarket change	1.31%
Premarket close	$10.66
Premarket price	$10.80
Premarket volume	4K
Previous close	$10.66
Price vs 150-day SMA	-36.72%
Price vs 20-day SMA	2.16%
Price vs 200-day SMA	-38.78%
Price vs 50-day SMA	-12.5%
Relative volume	0.83
Return from IPO open	-51.09%
Return from IPO price	-43.37%
RSI	44.04
Sharpe ratio	0.16
Sharpe ratio (3Y)	0.87
Sharpe ratio (5Y)	0.26
Sortino ratio	0.35
Sortino ratio (3Y)	1.73
Sortino ratio (5Y)	0.51
Volume	1.3M
Weekly RSI	37.2
YTD price change	-31.63%
YTD total return	-31.63%

Metric

Value

150-day SMA

$16.94

1D price change

1.88%

1M price change

-8.92%

1M total return

-8.92%

1W price change

-5.63%

1W total return

-5.63%

1Y price change

-12.99%

1Y return CAGR

-13%

1Y total return

-12.99%

20-day SMA

$10.49

200-day SMA

$17.51

3M price change

-52.48%

3M total return

-52.48%

3Y price change

285.61%

3Y return CAGR

56.8%

3Y total return

285.61%

50-day SMA

$12.25

50-day SMA vs 200-day SMA

50under200

52-week high

$25.77

52-week high date

2026-01-08

52-week low

$9.68

52-week low date

2026-10-07

5Y price change

-58.99%

5Y return CAGR

-16.33%

5Y total return

-58.99%

6M price change

-44.43%

6M total return

-44.43%

All-time high

$45.56

All-time high date

2021-09-07

All-time low

$2.44

All-time low date

2023-10-25

Average true range (ATR)

$0.61

Average volume

1.6M

Beta (1Y)

2.37

Beta (2Y)

1.4

Beta (5Y)

1.37

Change from 52-week high

-57.86%

Change from 52-week low

12.19%

Change from all-time high

-76.47%

Change from all-time low

339.34%

Change from open

0.74%

Day's gap

1.13%

Dollar volume

$14.3M

High price

$10.87

Low price

$10.49

Monthly RSI

46.79

Open price

$10.78

Position in 52-week range

97.37%

Premarket change

1.31%

Premarket close

$10.66

Premarket price

$10.80

Premarket volume

Previous close

$10.66

Price vs 150-day SMA

-36.72%

Price vs 20-day SMA

2.16%

Price vs 200-day SMA

-38.78%

Price vs 50-day SMA

-12.5%

Relative volume

0.83

Return from IPO open

-51.09%

Return from IPO price

-43.37%

RSI

44.04

Sharpe ratio

0.16

Sharpe ratio (3Y)

0.87

Sharpe ratio (5Y)

0.26

Sortino ratio

0.35

Sortino ratio (3Y)

1.73

Sortino ratio (5Y)

0.51

Volume

1.3M

Weekly RSI

37.2

YTD price change

-31.63%

YTD total return

-31.63%

Metric	Value
Float	54.5M
Float percentage	63.85%
Shares change (QoQ)	1.6%
Shares change (YoY)	11.91%
Shares held by insiders	0.53%
Shares held by institutions	80.73%
Shares outstanding	85.3M
Short % of float	37.93%
Short % of shares	24.22%
Short ratio	14 days

Metric

Value

Float

54.5M

Float percentage

63.85%

Shares change (QoQ)

1.6%

Shares change (YoY)

11.91%

Shares held by insiders

0.53%

Shares held by institutions

80.73%

Shares outstanding

85.3M

Short % of float

37.93%

Short % of shares

24.22%

Short ratio

14 days

Monte Rosa Therapeutics, Inc. (GLUE)

Price

Financial snapshot

Fair-value bridge

Latest news · GLUE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GLUE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on GLUE

Frequently asked questions